BRIEF published on 09/22/2025 at 17:50, 11 months 18 days ago Guerbet annonce la nomination d'un PDG par intérim dans le cadre d'un changement de direction Changement De Direction Guerbet Imagerie Médicale PDG Par Intérim Jerome Estampes
BRIEF published on 09/22/2025 at 17:50, 11 months 18 days ago Guerbet Announces Interim CEO Amid Leadership Change Interim CEO Guerbet Medical Imaging Leadership Change Jerome Estampes
PRESS RELEASE published on 09/22/2025 at 17:45, 11 months 18 days ago Guerbet : Change in General Management Guerbet appoints Jérôme Estampes as interim CEO, replacing David Hale. Smooth transition expected with Executive Committee support. Nominations process underway for new CEO CEO Appointment Guerbet Transition Jerome Estampes Nominations Process
BRIEF published on 09/15/2025 at 17:55, 11 months 25 days ago Guerbet révise à la baisse ses perspectives financières pour 2025 Objectifs Financiers Solutions D'imagerie Guerbet Baisse Des Revenus Perspectives 2025
BRIEF published on 09/15/2025 at 17:55, 11 months 25 days ago Guerbet Revises 2025 Financial Outlook Downward Financial Targets Revenue Decline Guerbet Imaging Solutions 2025 Outlook
PRESS RELEASE published on 09/15/2025 at 17:50, 11 months 25 days ago Guerbet : Adjustment of 2025 full-year financial targets Guerbet revises downward its 2025 financial targets due to supply reforms, customer mix shift, and operational issues. Revenue to decline, EBITDA margin revised, and free cash flow expected negative Financial Targets Revenue Decline Guerbet 2025 Downward Revision
PRESS RELEASE published on 09/15/2025 at 17:50, 11 months 25 days ago Guerbet : Ajustement des objectifs financiers annuels 2025 Guerbet ajuste ses objectifs financiers annuels 2025 avec une légère décroissance du CA et une révision à la baisse de la rentabilité, suite à des challenges en France et aux US Objectifs Financiers Guerbet Imagerie Médicale Décroissance Révision À La Baisse
BRIEF published on 08/13/2025 at 17:50, 1 year ago Guerbet: Capital Situation as of July 31, 2025 Share Capital Voting Rights AMF Treasury Shares Guerbet
BRIEF published on 08/13/2025 at 17:50, 1 year ago Guerbet : Situation du Capital au 31 Juillet 2025 Droits De Vote Capital Social AMF Guerbet Actions Autodétenues
PRESS RELEASE published on 08/13/2025 at 17:45, 1 year ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2025 Déclaration du nombre de droits de vote et d'actions composant le capital de la société selon les réglementations en vigueur Capital Droits De Vote Actions AMF Règlement Général
Published on 09/11/2026 at 15:25, 1 hour 17 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 1 hour 42 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 2 hours 12 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 2 hours 44 minutes ago BlackBerry Radar Advances Asset Intelligence for Transportation
Published on 09/11/2026 at 13:00, 3 hours 42 minutes ago Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 16:30, 12 minutes ago Belt and Road Summit in Hong Kong welcomes over 6,200 global leaders to explore new business opportunities
Published on 09/11/2026 at 16:00, 42 minutes ago Deutsche Postbank Funding Trust III published semi-annual report
Published on 09/11/2026 at 16:00, 42 minutes ago Form 8.3 - IPConcept (Luxemburg) S.A.: SONNTAG Premium
Published on 09/11/2026 at 15:29, 1 hour 13 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/11/2026 at 15:24, 1 hour 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Segro PLC
Published on 09/11/2026 at 07:00, 9 hours 42 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 9 hours 42 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 9 hours 42 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 21 hours 12 minutes ago Availability of the 2026 Interim Financial Report
